UnitedHealth, Amedisys and antitrust regulators will have a magistrate judge’s help in hashing out a solution to the DOJ’s ...

A federal judge in Maryland ordered the Justice Department and UnitedHealth Group to begin mediation on Aug. 18.

The U.S. Department of Justice’s (DOJ) lawsuit against Amedisys Inc. (NASDAQ: AMED) and UnitedHealth Group (NYSE: UNH) will ...

Amedisys (AMED) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a ...

Yet another shoe has dropped in the UnitedHealth Group/Amedisys saga. Last week, the Justice Department — along with the ...

The Department of Justice will head to mediation with UnitedHealth Group and Amedisys April 18 as part of an ongoing antitrust lawsuit. Both companies are attempting to finalize a $3.3 billion ...

AMED insiders have traded $AMED stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales. Here’s a ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on Amedisys (AMED – Research Report) yesterday and set a price target of $100.00.Stay ...

It has been about a month since the last earnings report for Amedisys (AMED). Shares have added about 1.3% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Amedisys' high Quality of Patient Care and Patient Satisfaction star ...

Learn more about whether Amedisys, Inc. or BrightSpring Health Services, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Amedisys (AMED) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives ...